<DOC>
	<DOCNO>NCT02554695</DOCNO>
	<brief_summary>This protocol address : 1 ) How gene expression change bone cell affect age ? 2 ) Is age associate decreased signal bone cell ? 3 ) How treatment osteoporosis medication denosumab affect bone cell signal ?</brief_summary>
	<brief_title>Osteoclast Inhibition Bone Formation</brief_title>
	<detailed_description>This protocol collectively address follow goal : 1 ) What change gene expression osteoblast osteocytes lead impaired bone formation age ; 2 ) Since recent work investigator ' group demonstrate osteoclast produce number growth factor cytokine ( couple factor ) enhance osteoblast proliferation and/or differentiation , age associate reduced osteoclast couple factor production ; 3 ) If osteoclast markedly reduce use FDA-approved medication osteoporosis , denosumab , effect quantity couple factor bone microenvironment target gene couple factor osteoblast ?</detailed_description>
	<mesh_term>Denosumab</mesh_term>
	<criteria>normal premenopausal woman age 2540 year normal postmenopausal woman age 6080 year least 5 yr since last menses follicle stimulate hormone ( FSH ) &gt; 20 IU/L Abnormality screen laboratory study Presence significant liver renal disease Malignancy ( include myeloma ) Malabsorption Diabetes Hypoparathyroidism Hyperparathyroidism Acromegaly Cushing 's syndrome Hypopituitarism Severe chronic obstructive pulmonary disease Undergoing treatment medication affect bone turnover , include follow : adrenocorticosteroids ( &gt; 3 month time &gt; 10 day within previous yr ) anticonvulsant therapy ( within previous year ) pharmacological dos thyroid hormone ( cause decline thyroid stimulate hormone normal ) calcium supplementation &gt; 1200 mg/d ( within precede 3 month ) bisphosphonates ( within past 3 yr ) denosumab estrogen ( E ) therapy within past year treatment selective E receptor modulator within past year teriparatide within past yr Clinical history osteoporotic fracture ( vertebral , hip , distal forearm ) Recent ( within past 6 month ) fracture Serum 25hydroxyvitamin D level &lt; 20 ng/ml</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>adrenergic</keyword>
</DOC>